Skip to main content

Erektile Dysfunktion

  • Chapter
  • First Online:
Medikamente in der Urologie

Zusammenfassung

In Anbetracht der demographischen Entwicklung mit einem Anstieg der älteren Bevölkerung werden auch bei Patienten in einem fortgeschrittenen Lebensalter andrologische Gesichtspunkte zunehmend bedeutender. Die mittlere Lebenserwartung eines Mannes stieg in den letzten 100 Jahren von 44,8 Jahren auf 74,4 Jahre.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover + eBook
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
  • Available as EPUB and PDF

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Becker AJ, Ückert S, Stief CG (2008) Grundlagen der Phosphodiesterase-5-(PDE5-)Inhibitoren. Urologe 47:1582–1587

    Article  CAS  Google Scholar 

  • Brandenburg U, Sperling H, Hartmann U et al (2002) Sexualität im Alter. Urologe 41:346–349

    Article  CAS  Google Scholar 

  • Chung E, Brock GB (2011) A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases. Expert Opin Pharmacother 12:1341

    Article  CAS  Google Scholar 

  • Curran M, Keating G (2003) Tadalafil. Drugs 63:2203

    Article  CAS  Google Scholar 

  • Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral Sildenafil in the treatment of erectile dysfunction. J Urol 167:1197–1203

    Article  Google Scholar 

  • Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, DiDonato K, Trask B, Day WW (2012) A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med 9:1122–1133

    Article  CAS  Google Scholar 

  • Guay AT, Perez JB, Velasquez E, Newton RA, Jacobson JP (2000) Clinical experience with intraurethral alprostadil (MUSE®) in the treatment of men with erectile dysfunction. Eur Urol 38:671–676

    Article  CAS  Google Scholar 

  • Guiliano F, Rubio-Auroiles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wilkins HJ, Wachs BH (2006) Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 66:201–216

    Google Scholar 

  • Guiliano F, Sanchez-Ramos A, Lochner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J (2007) Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol 64:1584–1592

    Article  Google Scholar 

  • Kim SC, Ahn TY, Choi HK, Chung TG, Chung WS, Hwang TK, Hyun JS, Jung GW, Kim CI, Kim JJ, Lee CH, Lee KS, Lee WH, Min KS, Moon KH, Paic JS, Park KS, Park NC, Park YK, Seo JK, Seo KK, Shin JS, Yoon YR, Lee WC (2000) Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea. Int J Impot Res 12:97–101

    Article  CAS  Google Scholar 

  • Lea AP, Bryson HM, Balfour JA (1996) Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction. Drugs Aging 8:56–74

    Article  CAS  Google Scholar 

  • Linet OI, Ogrinc FG (1996) Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 334:873–877

    Article  CAS  Google Scholar 

  • Moncada I, Cuzin B (2015) Clinical efficacy and safety of Vitaros©/Virirec© (Alprostadil cream) for the treatment of erectile dysfunction. Urologia 82:84–92

    Article  Google Scholar 

  • Mulhall JP, Burnett AL, Wang R, McVary KT, Moul JW, Bowden CH, DiDonato K, Shih W, Day WW (2013) A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol 189:2229–2236

    Article  CAS  Google Scholar 

  • Padma-Nathan H, Yeager JL (2006) An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients. Urology 68:386–391

    Article  Google Scholar 

  • Roehrborn CG, Egan KB, Miner MM, Ni X, Wong DG, Rosen RC (2016) Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment. BJU 118:153–160

    Article  CAS  Google Scholar 

  • Sperling H, Jockenhövel F, Stackl W et al (2006) LOH (late onset hypogonadism) oder „aging male“. Urologe 45:163–168

    Article  Google Scholar 

  • Wayne J, Hellstrom G, Elhilali M, Homering M, Taylor T, Gittleman M (2005) Vardenafil in patients with erectile dysfunction: achieving treatment optimization. J Androl 26:604–609

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angelika Kaminsky .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kaminsky, A., Sperling, H. (2021). Erektile Dysfunktion. In: Merseburger, A.S., Kramer, M.W. (eds) Medikamente in der Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61492-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-61492-1_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-61491-4

  • Online ISBN: 978-3-662-61492-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics